Back to Market Feed

Product Information

METOCLOPRAMIDE 10 MG/2 ML VIAL is a generic product labeled by Avenacy Inc., priced at $0.5290 per ML under NDC 83634077902. Its NADAC has been published 93 times since Nov 13, 2024.

FDA first approved this application on Dec 20, 2013. Its Orange Book therapeutic-equivalence code is AP.

METOCLOPRAMIDE 10 MG/2 ML VIAL

metoclopramide hydrochloride
$0.5290per ML

Strength

5 mg/mL

Manufacturer

Avenacy Inc.

NDC

83634077902

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

7/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204756

FDA Approved

12/20/2013

TE Code

AP

On Market Since

6/30/2024

Pharmacological Classes

Dopamine D2 Antagonists
Dopamine-2 Receptor Antagonist

Price Statistics

The NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has been published 93 times since Nov 13, 2024, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5290 per ML
All-time high$0.6016 (May 14, 2025)
All-time low$0.5162 (May 21, 2025)
52-week high$0.5732
52-week low$0.5178
Median price$0.5673
Average price$0.5601
Largest weekly change-14.2% (May 21, 2025)
Weeks tracked93
Tracking sinceNov 13, 2024

Price History

1W

0.0%

1M

0.0%

3M

+1.0%

6M

+2.1%

1Y

-6.8%

3Y

N/A

5Y

N/A

All

-12.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the metoclopramide hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

METOCLOPRAMIDE 5 MG TABLET
Generic
00093220401•Teva Pharmaceuticals USA Inc.
$0.0354
per EA
METOCLOPRAMIDE 5 MG TABLET
Generic
00093220405•Teva Pharmaceuticals USA Inc.
$0.0354
per EA
METOCLOPRAMIDE 5 MG TABLET
Generic
50228023201•ScieGen Pharmaceuticals, Inc.
$0.0354
per EA
METOCLOPRAMIDE 5 MG TABLET
Generic
50228023205•ScieGen Pharmaceuticals, Inc.
$0.0354
per EA
METOCLOPRAMIDE 5 MG TABLET
Generic
51079088620•Mylan Institutional LLC
$0.0354
per EA
METOCLOPRAMIDE 5 MG TABLET
Generic
60687062001•American Health Packaging
$0.0354
per EA
METOCLOPRAMIDE 5 MG TABLET
Generic
62559029501•ANI Pharmaceuticals, Inc.
$0.0354
per EA
METOCLOPRAMIDE 5 MG TABLET
Generic
83980001001•Ipca Laboratories Limited
$0.0354
per EA
METOCLOPRAMIDE 5 MG TABLET
Generic
83980001005•Ipca Laboratories Limited
$0.0354
per EA
METOCLOPRAMIDE 10 MG TABLET
Generic
00093220301•Teva Pharmaceuticals USA Inc.
$0.0438
per EA

Frequently asked questions

What is the NADAC price of METOCLOPRAMIDE 10 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 10 MG/2 ML VIAL, manufactured by Avenacy Inc., is $0.5290 per ML (NDC 83634077902), effective Aug 19, 2026.

How has the price of METOCLOPRAMIDE 10 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has declined 12.1%. It has been tracked across 93 weekly CMS publications since Nov 13, 2024.

What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 10 MG/2 ML VIAL?

Since Nov 13, 2024, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has ranged from a low of $0.5162 (May 21, 2025) to a high of $0.6016 (May 14, 2025), with a median of $0.5673 per ML.

Are there cheaper alternatives to METOCLOPRAMIDE 10 MG/2 ML VIAL?

No other NADAC-published product currently shares the active ingredient and strength of METOCLOPRAMIDE 10 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METOCLOPRAMIDE 10 MG/2 ML VIAL?

METOCLOPRAMIDE 10 MG/2 ML VIAL (NDC 83634077902) is labeled by Avenacy Inc., and CMS classifies it as a generic product.